Results 241 to 250 of about 2,035,560 (322)
Recombinant Human Neuregulin1‐β1 Significantly Reduces Schwannoma Growth in Mice
rhNRGβ1‐Replacement‐Therapy: Under physiological conditions, NRGβ1 is expressed on axons (in orange), where it activates ERBB2 receptors, facilitating successful nerve regeneration following injury. However, loss of NF2 leads to a reduction in NRGβ1‐expression and increased ErbB2 levels on Schwann cells (in green), which contributes to schwannoma ...
Julia P. Bischoff +7 more
wiley +1 more source
Causal Relationship Between Epilepsy, Status Epilepticus and Sleep-Related Traits: A Bidirectional Mendelian Randomization Study. [PDF]
Shin YW, Hong SB.
europepmc +1 more source
ABSTRACT Although there are as many as 40 preclinical models of the neurodevelopmental disorder Phelan McDermid syndrome (PMS, or 22q13.3 deletion syndrome), detailed phenotypic analyses to compare the effects of different pathogenic variants and inform treatment design are lacking.
Vic Lin +7 more
wiley +1 more source
[Clinical response to brivaracetam in two cases of drug-resistant juvenile absence epilepsy]. [PDF]
Sanabria Sanchinel AA +1 more
europepmc +1 more source
ABSTRACT The long‐term outcomes of regression in autism spectrum disorder (ASD) remain unclear. Previous evidence suggests that autistic individuals with regression have poorer adulthood outcomes across various indices than those without regression. We compared two groups—those with and without regression in ASD—among 168 participants from a population‐
Satoru Minami +4 more
wiley +1 more source
Precision neuromodulation in epilepsy: from shared targets to personalized circuits. [PDF]
Pati S.
europepmc +1 more source
Paediatric rare diseases: Can large language models assist off‐label prescribing?
Aims To evaluate the effectiveness and reliability of large language models (LLMs) in retrieving and synthesizing biomedical information to support off‐label drug prescribing in paediatric rare diseases, and to compare their performance with human‐authored references in terms of scientific rationale, adverse events and drug interactions.
Anna Flamigni +3 more
wiley +1 more source
All Influencing Factors Should Be Taken into Account When Calculating Outcome Predictors for Paediatric Status Epilepticus [Letter]. [PDF]
Finsterer J.
europepmc +1 more source
Aims Globally, Australia has the highest per capita consumption rate of pregabalin, commonly prescribed for neuropathic pain. Emerging evidence suggests pregabalin may be associated with the onset or recurrence of several potentially life‐threatening psychiatric events in some individuals.
Amy G. McNeilage +4 more
wiley +1 more source

